7 hrs ago | Freshnews
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the presentation of positive pre-clinical animal efficacy ...
11 hrs ago | Freshnews
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the presentation of positive pre-clinical animal efficacy ...
Two Studies Look at Promising Therapies for Liver Cancer
Over years or decades, a proportion of people with chronic hepatitis B or C virus infection will develop hepatocellular carcinoma , or primary liver cancer.
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the presentation of positive pre-clinical animal efficacy ...
Enzyme Expression Levels Correlated With Chemotherapy Drug Response
A method that could be applied widely to explore genetic basis of cancer drug resistance Why do cancer patients develop resistance to chemotherapy drugs, sometimes abruptly, after a period in which the drugs ...
CSHL scientists correlate enzyme expression levels with chemotherapy drug response
Why do cancer patients develop resistance to chemotherapy drugs, sometimes abruptly, after a period in which the drugs seem to be working well to reduce tumors or hold them in check? Although largely a mystery ...
BioAlliance Pharma suspends the Phase II/III trial of doxorubicin...
BioAlliance Pharma SA , the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announced today the suspension of its Phase II trial of doxorubicin Transdrug ...
Drug-carrying nanoparticles may help kill paediatric brain tumours
Washington, July 15: Scientists at Washington University in St. Louis say that they have moved a step closer to delivering cancer-killing medicines to paediatric brain tumours.
Low risk of relapse, but high mortality rate after chemotherapy for KS
Patients who receive treatment for Kaposi's sarcoma consisting of pegylated liposomal doxorubicin with potent antiretroviral therapy have a low rate of relapse, according to a retrospective Spanish study ...
Nanomaterials Key to New Strategies for Blocking Metastasis
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to ...
Topoisomerase II inhibition involves characteristic chromosomal expression patterns
The phenomenon of co-localization of transcriptionally upregulated genes showing similar expression levels is known across all eukaryotic genomes.
Drug-Infused Nanoparticles Stop Cancer From Spreading
By using tumor-targeting nanoparticles filled with chemotherapy drugs, scientists kept kidney and pancreas cancers from spreading through the bodies of mice.
Clear guidelines are lacking on the assessment of lymphatic dissemination and on the anatomic extent of this assessment Women undergoing lymphatic assessment for endometrial cancer should undergo full ...
New clinical trial for patients with asbestos-associated lung cancer
Participating patients will receive several rounds of targeted chemotherapy using the drugs cisplatin and doxorubicin via surgically implanted catheters.
In Vitro and in Vivo Evaluation of Doxorubicin Conjugates with the...
Tumor Biology Center, Breisacher Straβe 117, 79106 Freiburg, Federal Republic of Germany, Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, ...
this Month in Archives of Dermatology: This Month in Archives of Dermatology
Arch Dermatol. 2008;144 :720. Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Szary Syndrome Cutaneous T-cell lymphomas ...
News From The Journal Of The National Cancer Institute, June 10 2008
Main Category: Cancer / Oncology Also Included In: Biology / Biochemistry ; Clinical Trials / Drug Trials ; Breast Cancer Article Date: 11 Jun 2008 - 6:00 PDT Novel Targeted Therapy Reduces Chemoresistance in ...
A novel small molecule inhibitor reduced both endogenous and drug-induced resistance to chemotherapy in a mouse model of melanoma.
Novel PVA-Based Hydrogel Microparticles for Doxorubicin Delivery
Micro- and nanoparticles are considered suitable drug delivery systems for their unique features, such as a large surface to volume ratio, and for the possibility to tune their size and hydrophobicity.
Biotech Takes: Quintessence moves ahead despite bad result from competitor
Madison, Wis. - A few weeks ago, in this column , I wrote that folks at Madison-based Quintessence Bioscience eagerly anticipated the outcome of a Phase IIIb clinical trial that Alfacell Corp.